2015 Press Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
05/26/15Navidea Biopharmaceuticals to Present at Jefferies Global Healthcare ConferenceDownload PDF
05/12/15Navidea Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue GuidanceDownload PDF
05/11/15Navidea Secures $60 Million Loan with CRG; Funding to Support Lymphoseek® Commercialization and Advancement of Development PipelineDownload PDF
04/30/15Navidea Biopharmaceuticals to Announce First Quarter 2015 Financial Results on May 12, 2015Download PDF
04/27/15Navidea Divests NAV5001, a Non-Core, Development-Stage Imaging Agent for Parkinson's DiseaseDownload PDF
04/22/15Navidea Data for Manocept™ CD206 Targeting Platform Demonstrate Potential to Impact Tumor-Associated Macrophages and Kaposi’s Sarcoma Tumor CellsDownload PDF
04/15/15Macrophage Therapeutics Announces Manocept™ Results in Kaposi’s Sarcoma Studies to Be Presented at the American Association of Cancer Research (AACR)Download PDF
04/15/15Navidea Announces Lymphoseek® Presentations at Upcoming Medical ConferencesDownload PDF
03/25/15Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Data at Society of Surgical Oncology MeetingDownload PDF
03/20/15Macrophage Therapeutics to Expand Efforts Into CNS DiseasesDownload PDF
03/13/15Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Executes Securities Purchase Agreement for $2.5 Million Financing and Receives Initial FundingDownload PDF
03/05/15Navidea Announces Fourth Quarter and Full Year 2014 ResultsDownload PDF
03/05/15Navidea and Norgine Enter European Commercial Partnership for Lymphoseek®; Navidea to Receive $2 Million Upfront PaymentDownload PDF
02/27/15Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Appoints Leading Experts to Therapeutics-Focused Scientific Advisory BoardDownload PDF
02/26/15Navidea Biopharmaceuticals to Announce Fourth Quarter and Year-End 2014 Financial Results on March 5, 2015Download PDF
02/18/15Lymphoseek® Data Presented in European Medical Conference Reinforces Clinical Value in Head & Neck Cancer of the Oral CavityDownload PDF
02/17/15Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head and Neck Published in Annals of Surgical OncologyDownload PDF
02/09/15Navidea Reports Preliminary 2014 Revenue; Provides Update on New Commercial StrategyDownload PDF
02/02/15Navidea to Report Preliminary 2014 Revenue and Present at BIO CEO & Investor Conference February 9Download PDF
01/29/15Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of Surgical Oncology; Fewer Nodal Dissections RequiredDownload PDF
01/21/15Navidea’s Macrophage Therapeutics Unit Announces Plan for $2.5 Million FinancingDownload PDF
01/06/15Navidea Biopharmaceuticals to Present at Biotech Showcase 2015Download PDF
01/05/15Navidea Strengthens Leadership Team to Accelerate Lymphoseek® GrowthDownload PDF